Attention Deficit Disorder/Attention Deficit Hyperactivity Disorder Medications

Medications listed in the tables and non-FDA approved indications included in these retrospective criteria are not indicative of Texas Vendor Drug Program formulary coverage.

  • Revision history
    • October 21, 2022; September 2020; September 2018; December 2016; March 2015; February 2013; December 2012; May 2011; April 2011; March 2011; July 2008.
  • Initially developed
    • Oct. 2007